Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
D. Allan Butterfield, Fabio Di Domenico, Eugenio Barone
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1842, Iss. 9, pp. 1693-1706
Open Access | Times Cited: 357

Showing 1-25 of 357 citing articles:

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Clémence Cheignon, Mireia Tomas, Dominique Bonnefont–Rousselot, et al.
Redox Biology (2017) Vol. 14, pp. 450-464
Open Access | Times Cited: 1802
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Eric Tönnies, Eugenia Trushina
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1105-1121
Open Access | Times Cited: 1471
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
D. Allan Butterfield, Barry Halliwell
Nature reviews. Neuroscience (2019) Vol. 20, Iss. 3, pp. 148-160
Open Access | Times Cited: 1412
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Francesco Panza, Madia Lozupone, Giancarlo Logroscino, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 2, pp. 73-88
Open Access | Times Cited: 807
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Peipei Liu, Yi Xie, Xiao‐Yan Meng, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 573
Zinc and Oxidative Stress: Current Mechanisms
Dilina N. Marreiro, Kyria Jayanne Clímaco Cruz, Jennifer Beatriz Silva Morais, et al.
Antioxidants (2017) Vol. 6, Iss. 2, pp. 24-24
Open Access | Times Cited: 516
Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer’s Disease
Giuseppe Verdile, Kevin N. Keane, Vinícius Fernandes Cruzat, et al.
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 450
Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Haroon Khan, Hammad Ullah, Michael Aschner, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 59-59
Open Access | Times Cited: 394
The relationship between obesity and cognitive health and decline
Louise Dye, Neil Bernard Boyle, Claire Champ, et al.
Proceedings of The Nutrition Society (2017) Vol. 76, Iss. 4, pp. 443-454
Open Access | Times Cited: 365
Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease
D. Allan Butterfield, Debra Boyd‐Kimball
Journal of Alzheimer s Disease (2018) Vol. 62, Iss. 3, pp. 1345-1367
Open Access | Times Cited: 333
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
Carlotta Giorgi, Saverio Marchi, Inês C. M. Simões, et al.
International review of cell and molecular biology (2018), pp. 209-344
Open Access | Times Cited: 324
Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance andβ-Cell Dysfunction
Kevin N. Keane, Vinícius Fernandes Cruzat, Rodrigo Carlessi, et al.
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-15
Open Access | Times Cited: 322
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD
Antonella Tramutola, Judy C. Triplett, Fabio Di Domenico, et al.
Journal of Neurochemistry (2015) Vol. 133, Iss. 5, pp. 739-749
Closed Access | Times Cited: 307
Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/ RNS generation
Waqar Ahmad, Bushra Ijaz, Khadija Shabbiri, et al.
Journal of Biomedical Science (2017) Vol. 24, Iss. 1
Open Access | Times Cited: 292
Oxidative stress, protein modification and Alzheimer disease
Antonella Tramutola, Chiara Lanzillotta, Marzia Perluigi, et al.
Brain Research Bulletin (2016) Vol. 133, pp. 88-96
Closed Access | Times Cited: 269
Aberrant insulin signaling in Alzheimer's disease: current knowledge
Gaurav Bedse, Fabio Di Domenico, Gaetano Serviddio, et al.
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 263
Mouse Models of Alzheimer’s Disease
Gisela Esquerda-Canals, Laia Montoliu‐Gaya, Jofre Güell‐Bosch, et al.
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1171-1183
Closed Access | Times Cited: 257
The role of type 2 diabetes in neurodegeneration
Giuseppe Verdile, Stephanie Fuller, Ralph N. Martins
Neurobiology of Disease (2015) Vol. 84, pp. 22-38
Closed Access | Times Cited: 246
Diabetes mellitus and cognitive impairments
Elham Saedi, Mohammad Reza Gheini, Firoozeh Faiz, et al.
World Journal of Diabetes (2016) Vol. 7, Iss. 17, pp. 412-412
Open Access | Times Cited: 244
Metformin – a Future Therapy for Neurodegenerative Diseases
Magdalena Markowicz-Piasecka, Joanna Sikora, Aleksandra Szydłowska, et al.
Pharmaceutical Research (2017) Vol. 34, Iss. 12, pp. 2614-2627
Open Access | Times Cited: 226
Therapies for Prevention and Treatment of Alzheimer’s Disease
Jesus Mendiola-Precoma, Laura C. Berumen, Karla Padilla, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-17
Open Access | Times Cited: 225
Insulin and Insulin Resistance in Alzheimer’s Disease
Aleksandra Sędzikowska, Leszek Szablewski
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9987-9987
Open Access | Times Cited: 216
Insulin Resistance and Oxidative Stress in the Brain: What’s New?
Mateusz Maciejczyk, Ewa Żebrowska, Adrian Chabowski
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 874-874
Open Access | Times Cited: 204
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Henry Querfurth, Hankyu Lee
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 186
The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?
Elham Razani, Atieh Pourbagheri‐Sigaroodi, Ava Safaroghli‐Azar, et al.
Cell Stress and Chaperones (2021) Vol. 26, Iss. 6, pp. 871-887
Open Access | Times Cited: 142
Page 1 - Next Page

Scroll to top